Assessing IQVIA Holdings (IQV) Valuation After Sharp Three Month Share Price Pullback

IQVIA Holdings Inc -2.21%

IQVIA Holdings Inc

IQV

165.62

-2.21%

IQVIA Holdings Stock Moves After Recent Performance Shift

IQVIA Holdings (IQV) has drawn fresh attention after a sharp share price pullback, with the stock showing a 30% decline over the past month and a 23% decline over the past 3 months.

Stepping back, IQVIA Holdings’ recent 30 day share price return of a 29.76% decline and year to date share price return of a 25.93% decline sit alongside a 1 year total shareholder return of a 13.70% decline. Together, these figures point to fading momentum as investors reassess growth prospects and risk around the business.

If this move has you reassessing your exposure to healthcare and data driven names, it could be a good moment to scan our list of 25 healthcare AI stocks as potential ideas to research next.

With IQVIA trading at $166.94, screens flagging a value score of 6 and an implied discount to some intrinsic and analyst estimates, you have to ask: is weakness creating an opening, or is the market already assuming future growth?

Most Popular Narrative: 33.2% Undervalued

At $166.94, the most followed narrative for IQVIA Holdings points to a fair value near $250, framing the recent pullback as a sizable valuation gap.

Continued investment in and deployment of proprietary platforms and agentic AI solutions, coupled with strategic collaborations and industry recognitions, increase switching costs and provide competitive barriers, positioning IQVIA to capture greater market share and support long-term revenue growth and margin improvement.

Curious what earnings power and margin profile are reflected in that fair value, and how far profit expectations extend into the next few years? The full narrative presents a tightly modeled path for revenue, profitability and valuation multiples that goes well beyond recent share price moves.

Result: Fair Value of $250.00 (UNDERVALUED)

However, this bullish script could falter if CRO pricing pressure squeezes margins further, or if high leverage starts to constrain IQVIA’s investment and flexibility.

Build Your Own IQVIA Holdings Narrative

If you see the story differently or simply prefer to test the numbers yourself, you can build a tailored IQVIA view in just a few minutes: Do it your way.

A great starting point for your IQVIA Holdings research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If you stop with just one stock, you could miss out on opportunities that better fit your goals, risk comfort and income needs right now.

  • Target potential mispricing by checking out our carefully filtered list of 53 high quality undervalued stocks that combine quality fundamentals with appealing valuations.
  • Strengthen the defensive side of your portfolio by scanning our solid balance sheet and fundamentals stocks screener (45 results) for companies with sturdy finances that can support their operations.
  • Boost your income focus by reviewing our hand picked 12 dividend fortresses that offer higher yields while still clearing our fundamental checks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via